Gateway Cardiovascular Rsch Ctr Inc is a clinical research site located in St Louis, Missouri, United States 63128.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
Gateway Cardiovascular Rsch Ctr Inc has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Atherosclerotic Cardiovascular Disease.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Gateway Cardiovascular Rsch Ctr Inc has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Gateway Cardiovascular Rsch Ctr Inc has 1 clinical trials on record, with 1 currently active. Their work covers Atherosclerotic Cardiovascular Disease.
Gateway Cardiovascular Rsch Ctr Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.